{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T01:36:19Z","timestamp":1792373779618,"version":"4.4.0"},"reference-count":63,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2005,2]]},"DOI":"10.1016\/j.ijcard.2003.11.021","type":"journal-article","created":{"date-parts":[[2005,2,9]],"date-time":"2005-02-09T22:33:57Z","timestamp":1107988437000},"page":"379-387","source":"Crossref","is-referenced-by-count":42,"title":["Gynecological health of females with congenital heart disease"],"prefix":"10.1016","volume":"98","author":[{"given":"Mary M.","family":"Canobbio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph K.","family":"Perloff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea J.","family":"Rapkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2003.11.021_BIB1","series-title":"Congenital heart disease in the adult","first-page":"124","article-title":"Pregnancy in congenital heart disease. The mother and the fetus","author":"Perloff","year":"1996"},{"key":"10.1016\/j.ijcard.2003.11.021_BIB2","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0095-5108(18)30176-3","article-title":"Congenital cardiac disease and pregnancy","volume":"24","author":"Mendelson","year":"1997","journal-title":"Clin. Perinatol."},{"key":"10.1016\/j.ijcard.2003.11.021_BIB3","series-title":"Obstetrics and gynecology","first-page":"157","article-title":"Adolescence, menstruation and the climacteric","author":"Jones","year":"1994"},{"key":"10.1016\/j.ijcard.2003.11.021_BIB4","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/BF02310327","article-title":"Menstrual patterns in women with congenital heart disease","volume":"16","author":"Canobbio","year":"1995","journal-title":"Pediatr. Cardiol."},{"key":"10.1016\/j.ijcard.2003.11.021_BIB5","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/0735-1097(96)00234-3","article-title":"Pregnancy outcomes after the Fontan repair","volume":"28","author":"Canobbio","year":"1996","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2003.11.021_BIB6","series-title":"Clinical gynecologic oncology","author":"Disaia","year":"1997"},{"key":"10.1016\/j.ijcard.2003.11.021_BIB7","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/1097-0142(19850715)56:2<403::AID-CNCR2820560233>3.0.CO;2-X","article-title":"The behavior of endometrial hyperplasia: a long-term study of \u201cuntreated\u201d hyperplasia in 170 patients","volume":"56","author":"Kurman","year":"1985","journal-title":"Cancer"},{"key":"10.1016\/j.ijcard.2003.11.021_BIB8","doi-asserted-by":"crossref","first-page":"406","DOI":"10.7326\/0003-4819-109-5-406","article-title":"Adults with cyanotic congenital heart disease: hematologic management","volume":"109","author":"Perloff","year":"1988","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ijcard.2003.11.021_BIB9","series-title":"Cardiac problems in pregnancy: diagnosis and management of maternal and fetal disease","first-page":"397","article-title":"Anticoagulation in pregnancy","author":"McGehee","year":"1990"},{"key":"10.1016\/j.ijcard.2003.11.021_BIB10","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1093\/oxfordjournals.eurheartj.a060738","article-title":"Anticoagulation and pregnancy","volume":"16","author":"Oakley","year":"1995","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2003.11.021_BIB11","first-page":"122","article-title":"Hazards of oral anticoagulant during pregnancy","volume":"68","author":"Stevenson","year":"1980","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ijcard.2003.11.021_BIB12","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0140-6736(96)03487-3","article-title":"Stroke prevention in atrial fibrillation investigators: adjusted-dose warfarin versus low intensity, fixed-dose warfarin plus aspirin for high risk patients with atrial fibrillation","volume":"348","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2003.11.021_BIB13","first-page":"205","article-title":"Ovarian hemorrhage in ovulating women receiving anticoagulant therapy","volume":"29","author":"Hill","year":"1984","journal-title":"J. Reprod. Med."},{"key":"10.1016\/j.ijcard.2003.11.021_BIB14","first-page":"512","article-title":"Ovarian hemorrhage complicating anticoagulant therapy","volume":"41","author":"Manny","year":"1973","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ijcard.2003.11.021_BIB15","doi-asserted-by":"crossref","first-page":"642","DOI":"10.7326\/0003-4819-88-5-642","article-title":"Ovarian (corpus luteum) hemorrhage during anticoagulation therapy","volume":"88","author":"Tresch","year":"1978","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ijcard.2003.11.021_BIB16","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1097\/00000658-197205000-00004","article-title":"Necrosis of the female breast complicating oral anti-coagulant treatment","volume":"175","author":"Davis","year":"1972","journal-title":"Ann. Surg."},{"key":"10.1016\/j.ijcard.2003.11.021_BIB17","first-page":"1","article-title":"Fertility, family planning and women's health: new data from 1995 National Survey of Family Growth","volume":"23","author":"Abma","year":"1997","journal-title":"Vital Health Stat."},{"key":"10.1016\/j.ijcard.2003.11.021_BIB18","doi-asserted-by":"crossref","first-page":"24","DOI":"10.2307\/2991522","article-title":"Unintended pregnancy in United States","volume":"30","author":"Henshaw","year":"1998","journal-title":"Fam. Plann. Perspect."},{"key":"10.1016\/j.ijcard.2003.11.021_BIB19","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1136\/bmj.292.6519.526","article-title":"Oral contraceptive and venous thromboembolism: indices in a large prospective study","volume":"292","author":"Vessey","year":"1986","journal-title":"BMJ"},{"key":"10.1016\/j.ijcard.2003.11.021_BIB20","first-page":"517","article-title":"Effects of oral contraceptive on blood coagulation: a review","volume":"67","author":"Beller","year":"1985","journal-title":"Obstet. Gynecol. Surv."},{"key":"10.1016\/j.ijcard.2003.11.021_BIB21","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/S0002-9378(98)70293-5","article-title":"Oral contraceptives and arterial and venous thrombosis: a clinicians formulations","volume":"179","author":"Speroff","year":"1998","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ijcard.2003.11.021_BIB22","series-title":"Contraception technology","author":"Hatcher","year":"1998"},{"key":"10.1016\/j.ijcard.2003.11.021_BIB23","first-page":"83","article-title":"The progesterone-only pill and thrombosis","volume":"15","author":"Fotherby","year":"1989","journal-title":"Br. J. Fam. Plann."},{"key":"10.1016\/j.ijcard.2003.11.021_BIB24","series-title":"A clinical guide for contraception","author":"Speroff","year":"1992"},{"key":"10.1016\/j.ijcard.2003.11.021_BIB25","unstructured":"\u201cUpdate on Norplant Contraceptive Kits\u201d FDA Talk Papers. U.S. Food and Drug Administration, July 26, 2002."},{"key":"10.1016\/j.ijcard.2003.11.021_BIB26","doi-asserted-by":"crossref","first-page":"91S","DOI":"10.1016\/S0010-7824(98)00118-8","article-title":"The pharmacodynamics and efficacy of Implanon: an overview of the data","volume":"58","author":"Croxatto","year":"1998","journal-title":"Contraception"},{"key":"10.1016\/j.ijcard.2003.11.021_BIB27","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/bmj.303.6793.13","article-title":"Bone density in women receiving depot medroxyprogesterone acetate for contraception","volume":"303","author":"Cundy","year":"1991","journal-title":"BMJ"},{"key":"10.1016\/j.ijcard.2003.11.021_BIB28","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0022-3476(96)70148-8","article-title":"A prospective comparison of bone density in adolescent girls receiving depot medroxyprogesterone acetate (Depo-Provera), levonorgesterel (Norplant), or oral contraceptives","volume":"129","author":"Cromer","year":"1996","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ijcard.2003.11.021_BIB29","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0010-7824(99)00083-9","article-title":"Comparative safety, efficacy, and cycle control of Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiolcypionate injectable suspension) and Ortho-Novum oral contraceptive (norethendrone\/ethinyl estradioltriphasic)","volume":"60","author":"Kaunitz","year":"1999","journal-title":"Contraception"},{"key":"10.1016\/j.ijcard.2003.11.021_BIB30","first-page":"200","article-title":"A review of the association between intrauterine devices and acute pelvic inflammatory disease","volume":"20","author":"Cery","year":"1978","journal-title":"J. Reprod. Med."},{"key":"10.1016\/j.ijcard.2003.11.021_BIB31","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/0140-6736(92)91904-M","article-title":"Intrauterine devices and pelvic inflammatory disease: an international perspective","volume":"339","author":"Farley","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2003.11.021_BIB32","first-page":"1","article-title":"The intrauterine device and pelvic inflammatory disease revisited: new results from the Women's Health Study","volume":"72","author":"Lee","year":"1988","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ijcard.2003.11.021_BIB33","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/0002-9378(86)90422-9","article-title":"Infective endocarditis in obstetric and gynecologic practice","volume":"154","author":"Seaworth","year":"1986","journal-title":"Am. Obstet. Gynecol."},{"key":"10.1016\/j.ijcard.2003.11.021_BIB34","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1001\/jama.1997.03540460058033","article-title":"Prevention of bacterial endocarditis: recommendations by the American heart association","volume":"277","author":"Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2003.11.021_BIB35","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1111\/j.1471-0528.2000.tb11610.x","article-title":"Levonorgestre-releasing (20 microgram\/day) intrauterine systems (Mirena) compared with other methods of reversible contraceptives","volume":"107","author":"French","year":"2000","journal-title":"BJOG"},{"key":"10.1016\/j.ijcard.2003.11.021_BIB36","unstructured":"US Food and Drug Administration. FDA approves first hormonal vaginal contraceptive ring. Available: http:\/\/www.fda.gov\/bbs\/topics\/Answers\/2001\/ANSO2207.html. Accessed November 12,2001."},{"key":"10.1016\/j.ijcard.2003.11.021_BIB37","doi-asserted-by":"crossref","first-page":"142","DOI":"10.2165\/00003088-200039030-00005","article-title":"Pharmacokinetics of etonogestrel and ethinyl estradiol released from a combined contraceptive vaginal ring","volume":"39","author":"Timmer","year":"2000","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ijcard.2003.11.021_BIB38","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1001\/jama.285.18.2347","article-title":"Evaluation of contraceptive efficacy and cycle control of transdermal contraceptive patch vs. an oral contraceptive","volume":"285","author":"Audet","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2003.11.021_BIB39","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/0010-7824(82)90102-0","article-title":"The effectiveness of barrier methods of contraception with and without spermicide","volume":"26","author":"Craig","year":"1982","journal-title":"Contraception"},{"key":"10.1016\/j.ijcard.2003.11.021_BIB40","doi-asserted-by":"crossref","first-page":"226","DOI":"10.2307\/2135759","article-title":"Efficacy of the simultaneous use of condoms and spermicides","volume":"23","author":"Kestelman","year":"1991","journal-title":"Fam. Plann. Perspect."},{"key":"10.1016\/j.ijcard.2003.11.021_BIB41","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0899-5885(18)30239-9","article-title":"Gender-related considerations in clinical pharmacology and drug therapeutics","volume":"9","author":"Xie","year":"1997","journal-title":"Crit. Care Nurs. Clin. North Am."},{"key":"10.1016\/j.ijcard.2003.11.021_BIB42","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0140-6736(98)05145-9","article-title":"Randomized controlled trial of levonorgestrel versus the Yuzpe regimen of combined oral contraceptives for emergency contraception. Task Force on Postovulatory Methods of Fertility Regulation","volume":"352","year":"1998","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.ijcard.2003.11.021_BIB43","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1093\/oxfordjournals.humrep.a138057","article-title":"A prospective randomized comparison of levonorgestrel with the Yuzpe regimen in post-coital contraception","volume":"352","author":"Ho","year":"1993","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.ijcard.2003.11.021_BIB44","doi-asserted-by":"crossref","first-page":"180","DOI":"10.7326\/0003-4819-137-3-200208060-00010","article-title":"Emergency contraception","volume":"137","author":"Grimes","year":"2002","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ijcard.2003.11.021_BIB45","first-page":"437","article-title":"Laparoscoptic tubal legalism under direct anesthesia in women with cyanotic heart disease","volume":"78","author":"Snabes","year":"1991","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ijcard.2003.11.021_BIB46","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0010-7824(99)00009-8","article-title":"Interaction between broad-spectrum antibiotics and the combined oral contraceptive pill. A literature review","volume":"59","author":"Weaver","year":"1999","journal-title":"Contraception"},{"key":"10.1016\/j.ijcard.2003.11.021_BIB47","first-page":"392","article-title":"Reduced oral contraceptive effectiveness with concurrent antibiotic use: a protocol for prescribing antibiotics to women of childbearing age","volume":"11","author":"Donaly","year":"1990","journal-title":"Compendium"},{"key":"10.1016\/j.ijcard.2003.11.021_BIB48","series-title":"The whole truth about contraception","author":"Winikoff","year":"1998"},{"key":"10.1016\/j.ijcard.2003.11.021_BIB49","doi-asserted-by":"crossref","first-page":"472","DOI":"10.2165\/00003088-199018060-00004","article-title":"Pharmacokinetic drug interactions with oral contraceptives","volume":"18","author":"Back","year":"1990","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ijcard.2003.11.021_BIB50","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1111\/j.1365-2125.1990.tb05457.x","article-title":"The interaction of pheytoin and carbamazepine with combined oral contraceptive steroids","volume":"30","author":"Crawford","year":"1990","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.ijcard.2003.11.021_BIB51","first-page":"4","article-title":"FDA Approval of mifepristone: an overview","volume":"11","year":"2000","journal-title":"Contracept. Rep."},{"key":"10.1016\/j.ijcard.2003.11.021_BIB52","first-page":"1242","article-title":"Early pregnancy termination with mifepristone and misoprostol in the United States","volume":"333","author":"Spitz","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2003.11.021_BIB53","first-page":"13","article-title":"Longterm observations on the Blalock Taussig operation: VIII. 20 to 28 year follow-up on patients with a tetralogy of Fallot","volume":"137","author":"Taussig","year":"1975","journal-title":"John Hopkins Med. J."},{"key":"10.1016\/j.ijcard.2003.11.021_BIB54","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1136\/hrt.78.1.9","article-title":"Family planning requirements of adults with congenital heart disease","volume":"78","author":"Swan","year":"1997","journal-title":"Heart"},{"key":"10.1016\/j.ijcard.2003.11.021_BIB55","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/S0735-1097(01)01272-4","article-title":"Task Force I: changing profile of congenital heart disease in adult life. 32nd Bethesda Conference: care of the adult with congenital heart disease","volume":"37","author":"Warnes","year":"2001","journal-title":"JACC"},{"key":"10.1016\/j.ijcard.2003.11.021_BIB56","first-page":"205","article-title":"Menopause","volume":"24","author":"Thacker","year":"1997","journal-title":"Women's Health"},{"key":"10.1016\/j.ijcard.2003.11.021_BIB57","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/jama.1995.03520270033028","article-title":"Effects of estrogen or estrogen\u2013progestin regimens on heart disease risk factors in postmenopausal women","volume":"273","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2003.11.021_BIB58","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1001\/jama.280.7.605","article-title":"Randomized trial of estrogen and progestin for secondary prevention of coronary heart disease in women (HERS)","volume":"280","author":"Hulley","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2003.11.021_BIB59","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1001\/jama.287.15.1923","article-title":"Hormone replacement therapy falls out of favor with expert committee","volume":"287","author":"Vastag","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2003.11.021_BIB60","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in health postmenopausal women: principle results from the Women's Health Initiative randomized controlled trial","volume":"288","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2003.11.021_BIB61","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1001\/jama.1997.03540380054031","article-title":"Patient specific decisions about hormone replacement therapy in postmenopausal women","volume":"277","author":"Col","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2003.11.021_BIB62","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/S0015-0282(01)01791-5","article-title":"Relief of vasomotor symptoms and vaginal atrophy with lower doses of conjugated equine estrogens and medroxyprogesterone acetate","volume":"75","author":"Utian","year":"2001","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.ijcard.2003.11.021_BIB63","first-page":"159","article-title":"Guidelines for counseling postmenopausal women about preventive hormone therapy","volume":"6","author":"American College of Physicians","year":"1993","journal-title":"JABFP"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527304001299?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527304001299?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,29]],"date-time":"2019-01-29T11:58:11Z","timestamp":1548763091000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527304001299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2]]},"references-count":63,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,2]]}},"alternative-id":["S0167527304001299"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2003.11.021","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2005,2]]}}}